Investor Rights Agreement between Midas Gold Corp. and Barrick Gold Corporation, dated May 16, 2018

​

Exhibit 10.2

INVESTOR RIGHTS AGREEMENT

MIDAS GOLD CORP.

- and -

BARRICK GOLD CORPORATION

May 16, 2018

​

​

​

​

TABLE OF CONTENTS

​

​

-i-

​

​

​

​

-ii-

​

INVESTOR RIGHTS AGREEMENT

THIS AGREEMENT is made as of the 16^th day of May, 2018,

BETWEEN:

MIDAS GOLD CORP.,

a corporation existing under the laws of the Province of British Columbia,

(hereinafter referred to as the “Corporation”),

– and –

BARRICK GOLD CORPORATION,

a corporation existing under the laws of the Province of Ontario,

(hereinafter referred to as the “Investor”).

WHEREAS the Investor has agreed to purchase, on a private placement basis, 46,551,731 common shares of the Corporation (“Common Shares”), representing 19.9% of the issued and outstanding Common Shares (the “Share Offering”);

AND WHEREAS in connection with the closing of the Share Offering, the Corporation has agreed to grant certain rights to the Investor as set forth herein;

NOW THEREFORE, in consideration of the respective covenants and agreements of the Parties herein contained and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

ARTICLE 1

GENERAL

As used in this Agreement the following terms shall have the following respective meanings and grammatical variations of such terms shall have corresponding meanings:

“Acting Jointly or in Concert” has the meaning set forth in Section 8.1(a)(i);

“Acquired Voting Securities” has the meaning set forth in Section 8.2;

“Affiliate” means, with respect to any specified Person, any other Person which, directly or indirectly, through one or more Persons Controls, or is Controlled by, or is under common Control with, such specified Person;

“Agreement” means this investor rights agreement among the Corporation and the Investor, as amended from time to time in accordance with the terms hereof;

​

​

​

​

“Board” means the board of directors of the Corporation;

“Board Designee” has the meaning set forth in Section 3.1(a);

“Business Day” means a day other than a Saturday, Sunday or statutory holiday in the Province of British Columbia or in the Province of Ontario;

“Canadian Securities Authorities” means any of the securities commissions or similar securities regulatory authorities in each of the provinces and territories of Canada in which the Corporation is a reporting issuer (or has analogous status);

“Canadian Securities Laws” means all applicable Canadian securities laws, the respective regulations, rules and orders made thereunder, and all applicable policies and notices issued by the Canadian Securities Authorities in the applicable jurisdictions in Canada;

“CFPOA” has the meaning set forth in Section 5.1;

“Closing Date” means the closing date of the Share Offering;

“Common Shares” has the meaning set forth in the recitals hereto;

“Concentrate Interest” means (a) a right or interest created by an agreement to purchase and/or sell gold concentrate from, or measured based on, gold mined from, produced, extracted or otherwise recovered from the Stibnite Gold Project, as applicable, (b) a royalty interest, stream, offtake or any similar financial or physical interest in gold concentrate mined from, produced, extracted or otherwise recovered from the Stibnite Gold Project, or (c) an offsite treatment or processing agreement pursuant to which gold concentrate from gold mined from, produced, extracted or otherwise recovered from the Stibnite Gold Project, as applicable, is treated or processed;

“Confidential Information” has the meaning set forth in the Confidentiality Agreement;

“Confidentiality Agreement” means the confidentiality agreement between the Corporation and Barrick Gold Exploration Inc. dated as of August 18, 2017;

“Control”, “Controlled by” and “under common Control with”, as used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through the ownership of voting securities, by agreement or otherwise;

“Convertible Securities” means any security convertible, exchangeable or exercisable for or into, with or without consideration, Common Shares or other equity or voting securities of the Corporation, including any convertible debt securities, warrants, options or other rights issued by the Corporation;

“Corporation” has the meaning set forth in the preamble hereto;

“Demand Registration” has the meaning set forth in Section 7.1;

​

-2-

​

“Designated Registrable Securities” has the meaning set forth in Section 7.1;

“Distribution” means a distribution of Registrable Securities to the public by way of a Prospectus under Canadian Securities Laws in any applicable jurisdictions in Canada;

“Downsize Notice” has the meaning set forth in Section 4.4(b)(ii);

“Downsized Entitlement” has the meaning set forth in Section 4.4(b)(ii);

“Equivalency Determination Request” has the meaning set forth in Section 6.3(c);

“Excluded Dilutive Event” has the meaning set forth in Section 4.7;

“Exercise Notice” has the meaning set forth in Section 4.4(a);

“Existing Convertible Securities” means Convertible Securities issued prior to, and outstanding on, the Closing Date, other than any Convertible Securities issued pursuant to the Stock Option Plan or any predecessor stock option plan of the Corporation;

“Existing Participation Rights” has the meaning set forth in Section 4.9;

“FCPA” has the meaning set forth in Section 5.1;

“Fully Diluted Basis” means, with respect to the number of outstanding Common Shares at any time, the number of Common Shares that would be outstanding if all rights to acquire Common Shares were exercised, including all Common Shares issuable upon the conversion, exercise or exchange of Convertible Securities, and excluding, for the purposes of this calculation, all Common Shares issuable upon the conversion of any options under the Stock Option Plan or any other stock incentive plan;

“Governmental Entity” means: (a) any domestic or foreign government, whether national, federal, provincial, state, territorial, municipal or local (whether administrative, legislative, executive or otherwise); (b) any agency, authority, ministry, department, regulatory body, court, central bank, bureau, board or other instrumentality having legislative, judicial, taxing, regulatory, prosecutorial or administrative powers or functions of, or pertaining to, government; (c) any court, commission, individual arbitrator, arbitration panel or other body having adjudicative, regulatory, judicial, quasi-judicial, administrative or similar functions; or (d) any other body or entity created under the authority of or otherwise subject to the jurisdiction of any of the foregoing, including any stock or other securities exchange or professional association;

“Idaho Gold” means Idaho Gold Resources Company, LLC;

“Independent” means, in respect of an individual, that such individual is independent within the meaning of Canadian Securities Laws and the rules of each stock exchange on which the Corporation’s securities are listed;

“Independent Board Candidate” has the meaning set forth in Section 3.1(b);

“Independent Expert” has the meaning set forth in Section 6.3(d);

​

-3-

​

“Investor” has the meaning set forth in the preamble hereto;

“Issuance” has the meaning set forth in Section 4.1;

“Losses” has the meaning set forth in Section 7.8;

“Market Price” means, in respect of any date, the “Market Price” of the Common Shares as determined in respect of such date pursuant to the TSX Company Manual, or if the Common Shares are not traded on the TSX at the relevant time, the closing price of the Common Shares on the trading day immediately prior to such date on such other exchange or marketplace as such shares are then traded (or at the “Market Price” otherwise determined pursuant to the rules of such other exchange or marketplace, if different);

“MI 61-101” means Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions;

“NI 62-104” means National Instrument 62-104 – Take-Over Bids and Issuer Bids;

“Notice Period” has the meaning set forth in Section 4.4(a);

“Offered Securities” means any equity securities, voting securities or Convertible Securities of the Corporation;

“Offering” has the meaning set forth in Section 4.1;

“Offering Notice” has the meaning set forth in Section 4.1;

“Offering Shareholder” has the meaning set forth in Section 7.1(d);

“Offer Price” has the meaning set forth in Section 6.4(b)(iii);

“Participation Right” has the meaning set forth in Section 4.2;

“Parties” means, collectively, the Corporation and the Investor;

“Paulson” has the meaning set forth in Section 4.9;

“Paulson Investor Rights Agreement” has the meaning set forth in Section 4.9;

“Payment” has the meaning set forth in Section 5.1;

“Permitted Assign” means any Affiliate of the Investor;

“Permitted Offering” has the meaning set forth in Section 6.4(a);

“Person” means any individual, corporation or company with or without share capital, partnership, joint venture, association, trust, unincorporated organization, trustee, executor, administrator or other legal personal representative, Governmental Entity or entity however designated or constituted;

“Prohibited Recipient” has the meaning set forth in Section 5.1;

​

-4-

​

“Piggyback Registrable Securities” has the meaning set forth in Section 7.2;

“Piggyback Registration” has the meaning set forth in Section 7.2;

“Piggyback Registration Notice” has the meaning set forth in Section 7.2;

“Process for Prospectus Review” means process for prospectus review provided for under National Policy 11-202 – Process for Prospectus Review in Multiple Jurisdictions;

“Prospectus” means a preliminary prospectus, an amended preliminary prospectus or a final prospectus of the Corporation in respect of its securities which has been filed with the applicable Canadian Securities Authorities, including all amendments and all supplements thereto and all material incorporated by reference (or deemed to be incorporated by reference) therein;

“Receipt” means a final receipt, decision document or similar notice or document issued in respect of a Prospectus by a Canadian Securities Authority in accordance with the Process for Prospectus Review;

“Register”, “Registered” and “Registration” unless the context requires otherwise, refers to the filing of a Prospectus for the purposes of qualifying Registrable Securities under Canadian Securities Laws for Distribution in each of the provinces and territories of Canada in which the Corporation is a reporting issuer (or has analogous status);

“Registrable Securities” means:

“Registration Expenses” means all expenses incurred by the Corporation in connection with a Registration, including: (a) all fees, disbursements, expenses and commissions payable to any underwriter for an underwritten offering, agent for an agency offering and their respective counsel; (b) all fees, disbursements and expenses of counsel, the auditor to the Corporation and any other expert retained by the Corporation in connection with the Registration; (c) all expenses in connection with the preparation, translation, printing and filing of any Prospectus, and the mailing and delivering of copies thereof; (d) all qualification or filing fees of any Canadian Securities Authority and all fees and expenses of compliance with Canadian Securities Laws; (e) all transfer agents’, depositaries’ and registrars’ fees and the fees of any other agent appointed by the Corporation in connection with the Registration; (f) all fees and expenses payable in connection with the listing of any Registrable Securities on each stock exchange on which the Common Shares are then listed; (g) all printing, copying, mailing, messenger and delivery expenses; (h) all expenses reasonably incurred by the Investor in connection with the Registration, including all reasonable fees, disbursements and expenses of the Investor’s counsel, independent public accountants and other advisors; and (i) all costs and expenses

​

-5-

​

associated with the conduct of any “road show” related to such Registration and any related marketing activities;

“Request” has the meaning set forth in Section 7.1(a);

“ROFR Acceptance Notice” has the meaning set forth in Section 6.3(a);

“ROFR Offer” has the meaning set forth in Section 6.3(a);

“Shareholder” means a shareholder of the Corporation and “Shareholders” means all of them;

“Shareholder Securities” has the meaning set forth in Section 7.2;

“Share Offering” has the meaning set forth in the recitals hereto;

“Share Transaction” has the meaning set forth in Section 8.1(a)(i);

“Specified Securityholder” means a Person that has beneficial ownership of, or control or direction over, 10% or more of an outstanding class of voting securities of the Corporation or Convertible Securities convertible, exchangeable or exercisable for or into, with or without consideration, 10% or more of an outstanding class of voting securities of the Corporation;

“Specified Securityholder Transaction” has the meaning set forth in Section 8.1(b);

“Spring Event” has the meaning set forth in Section 8.1(c);

“Standby Commitment” has the meaning set forth in Section 6.4(c);

“Stibnite Gold Project” means the Stibnite Gold Project of the Corporation, located in the Stibnite-Yellow Pine mining district in central Idaho;

“Stock Option Plan” means the existing stock option plan of the Corporation, last approved by the Shareholders on May 11, 2017;

“Subsidiary” means, with respect to a corporation, company or limited liability company (the “Parent Corporation”), a corporation, company or limited liability company that is (a) Controlled by the Parent Corporation, (b) Controlled by one or more corporations, companies or limited liability companies each of which is Controlled by the Parent Corporation, or (c) is Controlled by a corporation, company or limited liability company that is Controlled by the Parent Corporation;

“Teck” has the meaning set forth in Section 4.9;

“Teck Subscription Agreement” has the meaning set forth in Section 4.9;

“Third Party” means any Person other than the Corporation and any of its Affiliates and the Investor and any of its Affiliates;

​

-6-

​

“Top-up Notice” has the meaning set forth in Section 4.3(b);

“Top-up Offering” has the meaning set forth in Section 4.3(c);

“Top-up Right” has the meaning set forth in Section 4.3(a)(i);

“Top-up Shares” has the meaning set forth in Section 4.3(a)(i);

“Top-up Threshold” has the meaning set forth in Section 4.3(a)(ii);

“Transaction” has the meaning set forth in Section 8.1(c)(i);

“Transfer” means to sell, assign, transfer or otherwise convey or dispose of (including any synthetic disposal of economic rights), or commit to do any of the foregoing;

“Treasury Shares” means voting securities of the Corporation owned by the Investor or any of its Affiliates and issued by the Corporation from treasury, other than treasury securities issued on the conversion, exercise or exchange of Convertible Securities acquired by the Investor or any of its Affiliates from Third Parties;

“Triggering Ownership Percentage” has the meaning set forth in Section 8.1(f);

“TSX” means the Toronto Stock Exchange;

“Underwriter Cutback” has the meaning set forth in Section 7.3;

“Upsize Notice” has the meaning set forth in Section 4.4(b)(i);

“Upsize Option” has the meaning set forth in Section 4.4(b)(i); and

“Valid Business Reason” has the meaning set forth in Section 7.1(b)(iii).

Except as may be otherwise specifically provided in this Agreement and unless the context otherwise requires, in this Agreement:

​

-7-

​

The recitals and following schedule form an integral part of this Agreement:

Schedule A – Form of Indemnity Agreement

Schedule B – Registration Procedures

Schedule C – Selection of Independent Expert

Except where otherwise expressly provided, all amounts in this Agreement are stated in Canadian dollars.

Time shall be of the essence of this Agreement.

ARTICLE 2

INVESTOR APPROVAL RIGHTS

The Corporation shall, during the term of this Agreement, use commercially reasonable efforts to:

​

-8-

​

provided that these covenants shall not restrict or prevent the Corporation from engaging in or completing any transaction which would result in the Corporation ceasing to be a “reporting issuer” or the Common Shares ceasing to be listed on the TSX, provided that: (i) the holders of Common Shares receive: (A) cash; (B) securities of an entity which is listed on a stock exchange in Canada or such other exchange as may be agreed upon by the Corporation; or (C) a combination of (A) and (B); or (ii) the Investor or the holders of the Common Shares have approved or otherwise consented to the transaction (by the requisite majority required under applicable securities and corporate law).

The Corporation shall not, without the prior written approval of the Investor, create or issue any class of shares or other equity securities having voting or other rights equal to or superior to the Common Shares.

The Corporation shall not, without (a) the prior written approval of the Investor or (b) the approval or consent of the holders of the Common Shares (by the requisite majority required under applicable securities and corporate law), undertake or cause any offering, sale or issuance of any securities of any Subsidiary to any Person other than the Corporation or an Affiliate of the Corporation.

The terms and conditions of the Confidentiality Agreement shall apply to any Confidential Information provided to the Investor by the Corporation under this Agreement until expiry of the Confidentiality Agreement in accordance with its terms. On expiry of the Confidentiality Agreement, the Investor agrees to use, and to use its commercially reasonable efforts to ensure that its representatives use, the same degree of care as the Investor uses to protect its own confidential information to keep confidential any Confidential Information furnished by the Corporation to the Investor, whether such information was provided prior to or following expiry of the Confidentiality Agreement (so long as such information is not in the public domain or would otherwise be excluded from the definition of “Confidential Information” contained in the Confidentiality Agreement), except that the Investor may disclose such Confidential Information: (a) to any Affiliate of the Investor for the purpose of evaluating its investment in the Corporation as long as such Affiliate is advised of the confidential nature of such information and agrees to keep such information confidential; (b) to any of its or its Affiliates’ officers, directors, employees, consultants, attorneys, accountants, and financial and technical advisors, provided that such Persons have a legitimate need to know such information and are advised of the confidential nature of such information and agree to keep such information confidential; or (c) to the extent legally required, if requested or compelled by law, Governmental Entity or other applicable judicial or governmental order, depositions, interrogatories, requests for information or documents in legal or administrative proceedings, or subpoena, civil investigative demand or other similar process. The foregoing obligations shall not apply to the Investor with respect to information that: (i) is or becomes generally available to the public on a

​

-9-

​

non-confidential basis through no breach by the Investor or its representatives of this Section 2.4; (ii) becomes available to Investor on a non-confidential basis from a source other than the Corporation or its representatives, if such source was not known by the Investor to be bound by a confidentiality agreement with, or other legal obligation of secrecy to, the Corporation; (iii) is already in the possession of the Investor prior to the time of disclosure by the Corporation or its representatives; (iv) is independently developed by the Investor or its representatives without use or reliance on the information described in the preceding clause; (v) is permitted in writing by the Corporation or its representatives to be disclosed to third parties on a non-confidential basis; or (vi) is otherwise in the public domain as a result of any of the foregoing. Nothing contained in this Section 2.4 shall restrict the Investor from trading in securities of other issuers or of the Corporation, except as required by applicable law.

ARTICLE 3

COMPOSITION AND BOARD MATTERS

(a)On the Closing Date, the Corporation agrees that the Board shall consist of seven directors. Of such directors, the Corporation covenants and agrees to appoint, within 15 days of the Closing Date, one individual selected by the Investor to serve on the Board (the “Board Designee”) until the next meeting of Shareholders at which the election of directors to the Board is considered. The Corporation covenants and agrees that it will procure the resignation of one director to facilitate the change to the composition of the Board contemplated by the preceding sentence.

(b)The Corporation covenants and agrees that, in addition to the right set out in Section 3.1(a), the Investor shall have the right to source for consideration by the Board (or the Corporate Governance and Nominating Committee) an additional individual who is Independent as a candidate to serve on the Board as the eighth director (an “Independent Board Candidate”). The Independent Board Candidate sourced by the Investor shall be mutually acceptable to the Board (or the Corporate Governance and Nominating Committee), acting reasonably, and if an individual sourced by the Investor is not mutually acceptable to the Board (or the Corporate Governance and Nominating Committee), the Investor shall continue to source individuals who are Independent until the Board (or the Corporate Governance and Nominating Committee) approves such an individual as an Independent Board Candidate. The Investor shall, as expeditiously as possible following the Closing Date, source such Independent Board Candidate (and make any successive suggestions that are required until the Independent Board Candidate is accepted by the Board (or the Corporate Governance and Nominating Committee)), acting reasonably, and, promptly following the identification of an acceptable Independent Board Candidate and in any event no later than 90 days following the Closing Date, the Board shall pass a resolution to: (i) increase the size of the Board by one person from seven directors to eight directors; and (ii) pass a resolution appointing the Independent Board Candidate to the Board.

(c)As long as the Investor owns in the aggregate 10% or more of the issued and outstanding Common Shares, the Investor shall continue to be entitled to designate one Board Designee and to source one Independent Board Candidate for election pursuant to the procedures set out in Section 3.1(b). For greater certainty, the Investor shall have the right but not the obligation to nominate a Board Designee.

​

-10-

​

(d)Notwithstanding any other provision of this Agreement, if at any time the Investor has a Triggering Ownership Percentage, the Investor agrees to take all commercially reasonable actions within its control to ensure that at least 50% of the directors on the Board are Independent.

(e)The Corporation shall in respect of every meeting of Shareholders at which the election of directors to the Board is considered, and at every reconvened meeting following an adjournment or postponement thereof, nominate for election to the Board one Board Designee and one Independent Board Candidate, and shall use its commercially reasonable efforts to obtain Shareholder approval for the election of the Board Designee and Independent Board Candidate at such meeting (including by soliciting proxies in favour of the Board Designee and Independent Board Candidate) and to that end, the Corporation shall (i) support the Board Designee and Independent Board Candidate for election in a manner no less rigorous or favourable than the manner in which the Corporation supports all of its other nominees, and (ii) use commercially reasonable efforts to cause management of the Corporation to vote their Common Shares, and the Common Shares in respect of which management is granted a discretionary proxy, in favour of the election of the Board Designee and Independent Board Candidate at such meeting.

(f)In the event that a Board Designee is not elected to the Board at a meeting of Shareholders or a Board Designee resigns as a director or otherwise refuses to or is unable to serve as a director for any reason, including as a result of death or disability, the Investor shall be entitled to designate a replacement director and the Corporation agrees to appoint, subject to applicable laws and TSX requirements, such individual to the Board to serve as a Board Designee until the next meeting of Shareholders at which the election of directors to the Board is considered.

(g)In the event that an Independent Board Candidate is not elected to the Board at a meeting of Shareholders, resigns as a director or otherwise refuses to or is unable to serve as a director for any reason including as a result of death or disability, or if the Investor determines at any time and for good reason that an Independent Board Candidate is not a suitable candidate for director, the Investor shall be entitled to source for consideration by the Board (or the Corporate Governance and Nominating Committee) a replacement director that is acceptable to the Board (or the Corporate Governance and Nominating Committee), acting reasonably, in accordance with the procedures set out in Section 3.1(b), and the Corporation agrees to appoint, subject to applicable laws and TSX requirements, such individual to the Board to serve as an Independent Board Candidate until the next meeting of Shareholders at which the election of directors to the Board is considered.

(h)As long as the Investor owns in the aggregate 10% or more of the issued and outstanding Common Shares and has exercised its right to nominate a Board Designee, the Investor shall be entitled to designate its Board Designee to any special committee formed by the Corporation to consider a material transaction; provided that the Board Designee is not in a conflict of interest in relation to such transaction, as determined by the Board, acting reasonably.

(i)Any employee of the Investor who serves as a Board Designee shall not be entitled to any salary or compensation from the Corporation for his or her service as a director of the Corporation. Notwithstanding the foregoing, each Board Designee shall be entitled to the benefit of customary director’s and officer’s liability insurance and a contractual indemnity agreement with the Corporation in substantially the form attached hereto as Schedule A. All directors and officers (including existing directors and officers) of the Corporation shall be

​

-11-

​

entitled to the same director’s and officer’s liability insurance and the same form of contractual indemnity agreement with Corporation as each Board Designee.

(j)The Investor shall advise the Corporation of the identity of any Board Designee at least ten Business Days prior to the date on which proxy solicitation materials are to be mailed (as advised by the Corporation to the Investor) for purposes of any meeting of Shareholders at which the election of directors to the Board is to be considered. If the Investor does not advise the Corporation of the identity of any such Board Designee prior to such deadline, then the Investor shall be deemed to have nominated its incumbent nominee. The Corporation shall advise the Investor of the mailing date of any such proxy solicitation materials at least 20 Business Days prior to such date.

If, at any time, the Board is comprised of seven directors, the matters set out below shall require the approval of at least six of the seven directors of the Corporation or, if less than seven directors are entitled to vote on a matter, the unanimous approval of the directors voting on the matter, and following the increase of the Board of directors to eight directors as contemplated in Section 3.1(b), the approval of at least seven of the eight directors of the Corporation or, if less than eight directors are entitled to vote on a matter, the unanimous approval of the directors voting on the matter, in each case subject to the fiduciary duties of the directors:

The Corporation agrees and undertakes that, so long as the Investor owns in the aggregate 10% or more of the issued and outstanding Common Shares:

​

-12-

​

The Corporation agrees and undertakes that, so long as the Investor owns in the aggregate 10% or more of the issued and outstanding Common Shares, at the option of the Investor, exercisable in its sole discretion, one of the Investor’s Board Designees, if a Board Designee has been nominated by the Investor, or another individual designated by the Investor, shall be appointed as a member of any technical or project committee of the Board or otherwise, including any project steering committee or other committee or group charged with evaluating, making recommendations or otherwise overseeing any or all aspects of the mining, processing or permitting of the Stibnite Gold Project.

ARTICLE 4

PARTICIPATION RIGHT & TOP-UP RIGHT

Subject to Section 4.8, provided that the Investor owns at least 10% of the issued and outstanding Common Shares, if the Corporation proposes to issue (the “Issuance”) any Offered Securities pursuant to a public offering, a private placement or otherwise (but excluding any issuances of Common Shares in respect of which the Top-up Right (as defined below) would be applicable) (each, an “Offering”) at any time after the date hereof, the Corporation will, forthwith, but in any event by the date on which the Corporation files a preliminary prospectus, registration statement or other offering document in connection with an Issuance that constitutes a public offering of Offered Securities, and at least seven Business Days prior to the expected completion date of the Issuance, give written notice of the Issuance (the “Offering Notice”) to the Investor including, to the extent known by the Corporation, full particulars of the Offering, including the number of Offered Securities, the rights, privileges, restrictions, terms and conditions of the Offered Securities, the price per Offered Security to be issued under the Offering, the name of any agent(s) or underwriter(s) expected to be involved in the Offering, the intended form of the Offering (e.g., bought deal, overnight marketed, fully marketed, private placement, etc.), the expected use of proceeds of the Offering, the expected closing date of the Offering and the relative entitlements of the Investor, Paulson and Teck to participate in the Offering based on the information available to the Corporation at such time. In addition, the Corporation shall promptly, and in any event within one Business Day of receipt of such information from Teck and Paulson, respectively, confirm in writing to the Investor the intention of each of Teck and Paulson to subscribe for and purchase Common Shares and/or Offered Securities pursuant to their respective Existing Participation Rights in connection with each Offering, if applicable.

The Corporation agrees that, subject to Section 4.8, provided that the Investor owns at least 10% of the issued and outstanding Common Shares, the Investor (directly or through an Affiliate, in which case the provisions of this Article 4 shall apply mutatis mutandis) has the right (the “Participation Right”) to subscribe for and to be issued as part of an Offering, at the offering price per Offered Security determined pursuant to Section 4.6(a), and otherwise on substantially the same terms and conditions of the Offering (provided that, if the Investor is prohibited by Canadian Securities Laws or other applicable law from participating on substantially the same terms and conditions of the Offering, the Corporation shall use commercially reasonable efforts to

​

-13-

​

enable the Investor to participate on terms and conditions that are as substantially similar as circumstances permit):

(a)Without limiting Section 4.2, the Corporation agrees that, subject to the terms of this Section 4.3 and Section 4.8, provided that the Investor owns at least 10% of the issued and outstanding Common Shares:

(b)Subject to Section 4.3(d), within 10 Business Days of the date on which one or more Dilutive Conversions occurs resulting in the Top-up Threshold being achieved, the Corporation shall deliver a written notice (a “Top-up Notice”) to the Investor notifying the Investor that its Top-up Right has become exercisable and setting out the number of Existing Convertible Securities converted, exercised or exchanged into Common Shares, and the total number of issued and outstanding Common Shares following such Dilutive Conversions and any other conversions, exercises and exchanges of Convertible Securities from the end of the last period in respect of which a Top-up Notice was delivered.

​

-14-

​

(c)Subject to Section 4.5(c) and Section 4.5(d), if the Investor delivers an Exercise Notice in accordance with Section 4.4, the Corporation shall in accordance with the provisions of this Article 4, promptly, and in any event within 30 days of the date on which the relevant Top-up Notice was delivered, complete an offering to the Investor of the number of Top-up Shares that the Investor wishes to subscribe for pursuant to the Top-up Right, as specified in the Exercise Notice, at an offering price per Top-up Share determined pursuant to Section 4.6(b) (each, a “Top-up Offering”).

(d)Notwithstanding Section 4.3(a), Section 4.3(b) or Section 4.3(c), if a Top-up Threshold is achieved in, or is determined by the Corporation, acting reasonably, to be likely to occur prior to the date on which a record date for a meeting of Shareholders is to be set, prior to setting such record date the Corporation shall deliver a Top-up Notice to the Investor and, if the Investor delivers an Exercise Notice in accordance with Section 4.4 in response to a Top-up Notice delivered pursuant to this Section 4.3(d), the Corporation shall in accordance with the provisions of this Article 4, promptly, and in any event prior to declaring the record date for such Shareholder meeting, complete a Top-up Offering to the Investor.

(a)If the Investor wishes to exercise the Participation Right or the Top-up Right, the Investor shall give written notice to the Corporation (the “Exercise Notice”) of its intention to exercise such right and of the number of Offered Securities or Top-up Shares that the Investor wishes to subscribe for and purchase pursuant to the Participation Right or the Top-up Right, as applicable. The Investor shall deliver an Exercise Notice to subscribe to the Offering, Issuance or issuance of Top-up Shares within five Business Days after the date of receipt of an Offering Notice or Top-up Notice, as applicable, or in the case of a public offering that is a bought deal, within two Business Days of receipt of an Offering Notice (the “Notice Period”), failing which the Investor will not be entitled to exercise the Participation Right or the Top-up Right in respect of such Offering, Issuance or issuance of Top-up Shares and any rights that the Investor may have had to subscribe for any of the Offered Securities or Top-up Shares, as applicable, shall be extinguished, in respect of such Offering, Issuance or issuance of Top-up Shares.

(b)Each Exercise Notice shall constitute a binding agreement by the Investor to subscribe for and take up, and by the Corporation to issue and sell to the Investor, the number of Offered Securities or Top-up Shares, as applicable, that the Investor agrees to subscribe for in its Exercise Notice.

​

-15-

​

(a)The Corporation agrees to take any and all commercially reasonable steps as are required to facilitate the rights of the Investor set forth in this Article 4, including: (i) undertaking a private placement or directed offering of Offered Securities to the Investor as part of such Offering or Issuance; (ii) if required, increasing the size of the Offering or Issuance to satisfy its obligations to the Investor pursuant to Sections 4.2 through 4.4, inclusive, and its obligations to each of Paulson and Teck pursuant to the Existing Participation Rights; and (iii) undertaking a private placement of Top-up Shares to the Investor, in each case, subject to obtaining any regulatory or other approvals required by applicable law or the TSX and any other stock exchange on which the Common Shares are then listed and/or traded.

(b)If the Corporation receives an Exercise Notice from the Investor within the Notice Period, then the Corporation shall use its commercially reasonable efforts to obtain all required approvals (including the approval(s) of the TSX and any other stock exchange on which the Common Shares are then listed and/or traded and any required approvals under Canadian Securities Laws and, subject to Section 4.5(c), any Shareholder approval required under applicable law, including by using commercially reasonable efforts to cause management and each member of the Board to vote their Common Shares and any shares of the Corporation entitled to vote on the matter and all votes received by proxy in favour of the issuance of the Offered Securities or the Top-up Shares, as applicable, to the Investor), in order to issue to the Investor, against payment of the subscription price payable in respect thereof (as determined pursuant to Section 4.6(a) or 4.6(b), as applicable), that number of Common Shares or other Offered Securities, as applicable, set forth in the Exercise Notice.

(c)If the Corporation is required by the TSX or otherwise under applicable law to seek Shareholder approval for the issuance of the Offered Securities or the Top-up Shares, as applicable, to the Investor, then the Corporation shall: (i) call and hold a meeting of its Shareholders to consider the issuance of the Offered Securities or the Top-up Shares, as applicable, to the Investor as soon as reasonably practicable, and in any event such meeting shall be held within 60 days after the date that the Corporation is advised by the TSX or other applicable Governmental Entity that

​

-16-

​

it will require Shareholder approval; and (ii) recommend approval of the issuance of the Offered Securities or the Top-up Shares, as applicable, to the Investor and shall solicit proxies in support thereof. The Investor shall have a reasonable advance right to review and provide comments on all materials to be provided to the Shareholders in connection with such meeting, and the Corporation shall give reasonable consideration to all such comments made and shall incorporate all comments that relate to or refer to the Investor, to the extent commercially reasonable.

(d)If the purchase and sale of any Offered Securities or Top-up Shares, as applicable, to the Investor is delayed as a result of the need to obtain TSX, Shareholder or any other approval: (i) such sale shall be completed within five Business Days of receipt of the last of such required approvals; and (ii) any decrease in the percentage ownership interest of the Investor occurring between the time of the delivery of the Offering Notice or Top-up Notice and the issuance of Offered Securities or Top-up Shares, as applicable, to the Investor pursuant to its Exercise Notice shall be disregarded for all purposes of this Agreement and, notwithstanding any other provision of this Agreement, the percentage ownership interest of the Investor shall be deemed to be unchanged until the Offered Securities or Top-up Shares, as applicable, subscribed by the Investor in its Exercise Notice have been issued and sold to the Investor.

(a)The Participation Right will be exercisable by the Investor at the offering price made available by the Corporation to other investors in such Offering; provided that if the offering price is lowered by the Corporation in the course of any such Offering, the Investor will be entitled to pay the lowest price paid to the Corporation by any investor in the relevant Offering without regard to any applicable fees or commissions (except for any such fees or commissions that are paid or payable to the ultimate beneficial purchasers of such Offered Securities) in respect of each class of securities issued (and the Investor will be entitled to a refund (to be paid to the Investor within two Business Days of completion of the Offering) to the extent that it has already remitted funds to the Corporation in payment in connection with such Offering) and otherwise on substantially the same terms and conditions offered to other investors in the Offering.

(b)The Top-up Right will be exercisable by the Investor at the Market Price calculated as at the date on which the Top-up Notice is delivered. For greater certainty, each Top-up Offering will be an offering of Common Shares, unless otherwise agreed by the Investor in its sole discretion.

(c)If the Corporation has not issued the Offered Securities in connection with an Offering within 90 days of the expiry of the relevant Notice Period, the Corporation shall not thereafter proceed with such Offering without providing the Investor with a new Offering Notice and further opportunity to deliver an Exercise Notice in respect of such Offering.

(d)Notwithstanding any other provision of this Article 4, if any Offering is to be conducted on a bought deal basis, then the Investor may, in its sole discretion, choose not to participate in the bought deal but instead elect, within five Business Days after the date of receipt of an Offering Notice, to exercise its rights under this Agreement through a private placement to be completed concurrently with, or within three Business Days following, the completion of such bought deal and, in such case, shall notify the Corporation in its Exercise Notice of its election pursuant to this Section 4.6(d).

​

-17-

​

Notwithstanding anything to the contrary contained herein, Sections 4.1 to 4.6, inclusive, will not apply to any Issuances in the following circumstances (each such Issuance pursuant to paragraph 4.7(a) through 4.7(f), inclusive, being referred to as an “Excluded Dilutive Event”):

For the purposes of Section 3.1(c), Section 3.1(h), Section 3.3, Section 3.4, Section 7.1, Section 9.1 and this Article 4, in determining whether the Investor owns, directly or indirectly, at any time at least 10% of the issued and outstanding Common Shares:

​

-18-

​

Notice Period, in which case the Common Shares issued in connection with such Dilutive Conversion shall be counted from the date on which the Top-up Shares are issued and sold to the Investor.

(a)The Investor and the Corporation acknowledge the anti-dilution rights (the “Existing Participation Rights”) of:

(b)The Corporation acknowledges and agrees that it will comply with its obligations to the Investor contained in Article 4 and the anti-dilution rights of each of Teck and Paulson described in Section 4.9(a), to the extent that such rights are engaged in connection with any Issuance or Offering, in a coordinated manner and as part of such Issuance or Offering so as to ensure that the exercise of any such right does not trigger or give rise to any further or consequential pre-emptive right of any of the Investor, Teck or Paulson.

ARTICLE 5

ANTI-CORRUPTION

The Corporation shall not make, and shall cause its Affiliates not to make, any promise, offer, or transfer, either directly or indirectly, of any money, other assets or services, or other things of value, including but not limited to the payments derived by the Corporation from the Investor (each, a “Payment”), to any employee, officer, agent, or representative of any Governmental Entity, foreign political party or public international organization, or a candidate for political office, or any individual acting in an official capacity for any Governmental Entity (each a “Prohibited Recipient”), where such Payment would constitute a violation of the Foreign Corrupt Practices Act of 1977 (United States), as amended, and the rules and regulations thereunder (the “FCPA”), any applicable state law of the United States of America regarding corruption, the Corruption of Foreign Public Officials Act (Canada) (the “CFPOA”) or any similar law or regulation of any other country that may reasonably possess legal jurisdiction over the Corporation or the Investor. In addition, regardless of legality, the Corporation shall not offer, promise or make any Payment either directly or indirectly to a Prohibited Recipient if such Payment is for the purpose of influencing decisions or action or securing improper influence or any improper advantage. The Corporation will monitor, and will cause its Affiliates to monitor, their respective businesses and adopt, appropriately implement and maintain anti-corruption policies, procedures and internal controls (including internal accounting controls to keep and

​

-19-

​

maintain accurate and reasonably detailed books and financial records of expenses, receipts, payments made or received in connection with its business), to ensure:

The Corporation will conduct, and will cause its Affiliates to conduct, its and their operations at all times in compliance with all material applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970 (United States), as amended, the Proceeds of Crime (Money Laundering) and Terrorist Financing Act (Canada), the money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar applicable rules, regulations or guidelines, issued, administered or enforced by any Governmental Entity.

The Corporation will not directly or indirectly use any funds advanced by the Investor, or lend, contribute or otherwise make available any such funds to any of its Affiliates, any joint venture partner or other Person or entity, for the purpose of financing the activities of any Person subject to any United States sanctions administered by the Office of Foreign Assets Control of the United States Treasury Department.

Upon receipt of information that any obligation of the Corporation pursuant to this Article 5 has been violated, the Investor shall have the right to conduct an audit of the Corporation to ensure compliance with the requirements of this Article 5. The Corporation will provide such periodic certificates of compliance in respect of this Article 5 as may from time to time be reasonably requested in writing by the Investor.

ARTICLE 6

COVENANTS OF THE CORPORATION

The Corporation shall cause its Affiliates to conduct their business and affairs in a manner consistent with, and so as to give full effect to, all of the terms and conditions of this Agreement.

​

-20-

​

The Corporation covenants and agrees that any shareholder rights plan or similar instrument, or advance notice by-law or policy or similar instrument, of or adopted by the Corporation shall not restrict, limit, prohibit or conflict with the exercise by the Investor of its nomination rights under Section 3.1 or its Participation Right or Top-up Right in Article 4.

(a)The Corporation covenants and agrees that it shall not, nor shall it permit its Affiliates to, directly or indirectly, Transfer all or any part of a Concentrate Interest without first complying with this Section 6.3.

(b)If, at any time and from time to time, the Corporation or any of its Affiliates wishes to or enters into a bona fide agreement to sell a Concentrate Interest to, or receives a legally binding bona fide offer to purchase a Concentrate Interest from any Third Party, which offer or agreement the Corporation or such Affiliate is willing to accept, then the Corporation shall give the Investor written notice thereof, which notice must include the terms and conditions of such offer or agreement to purchase and, if available, a copy of such offer or draft agreement (the “ROFR Offer”). The Investor shall have the right, upon delivery to the Corporation of written notice of its intention to accept the ROFR Offer within 45 days from the date of delivery to the Investor of the ROFR Offer (a “ROFR Acceptance Notice”), to exercise its right of first refusal in respect thereof and to acquire such Concentrate Interest on substantially the same terms and conditions as are set forth in the ROFR Offer or on such other terms and conditions that provide substantially equivalent benefits to the Corporation having regard to the financial, commercial and other relevant terms. For greater certainty, in comparing the ROFR Offer to the offer contained in the ROFR Acceptance Notice, any equity or debt financing component proposed in the ROFR Offer, or any other unrelated transaction that is proposed in conjunction with the purchase of a Concentrate Interest, shall be disregarded when assessing the relative benefits to the Corporation. In addition, the offer contained in the ROFR Acceptance Notice need not replicate any financing terms of the ROFR Offer which provide for payment of consideration in a form other than cash, provided that consideration equivalent in value to the consideration proposed in the ROFR Offer is included in the ROFR Acceptance Notice.

(c)The delivery of a ROFR Acceptance Notice by the Investor shall automatically, without any further action or documentation, give rise to a binding obligation to enter into an agreement between the Corporation and the Investor pursuant to which binding obligation the Corporation shall be legally bound to sell to the Investor, and the Investor shall be legally bound to purchase from the Corporation the Concentrate Interest on the terms set forth in the ROFR Acceptance Notice, subject only, if requested by the Corporation in writing within 10 days of receipt of the ROFR Acceptance Notice (an “Equivalency Determination Request”), to confirmation by an Independent Expert that the terms of the ROFR Offer and those contained in the ROFR Acceptance Notice (as modified by any subsequent agreement of the Parties) provide substantially equivalent benefits to the Corporation having regard to the financial, commercial and other relevant terms.

(d)If an Equivalency Determination Request is delivered by the Corporation pursuant to Section 6.3(c), the Parties shall select an Independent Expert in accordance with the procedures set out in Schedule C (the individual so selected being referred to as an “Independent Expert”)

​

-21-

​

to determine whether the benefits to the Corporation of the ROFR Offer and those contained in the ROFR Acceptance Notice (as modified by any subsequent agreement of the Parties) are substantially equivalent having regard to the financial, commercial and other relevant terms. The Independent Expert appointed pursuant to this Section 6.3(d) shall render its determination in writing within 30 days of being retained and any such determination shall be final and binding upon the Parties and shall, absent manifest error, not be subject to appeal. The Parties shall each pay one half of the costs and expenses associated with the retention of any and all Independent Expert retained pursuant to this Section 6.3.

(e)If: (i) the Investor does not accept the ROFR Offer within 45 days from the date of delivery to the Investor of the notice thereof; or (ii) if the Corporation has requested an Equivalency Determination Request and the Independent Expert determines that the terms contained in the ROFR Acceptance Notice are not substantially equivalent to the terms of the ROFR Offer and the Parties have negotiated in good faith to attempt to reach a mutually satisfactory agreement for the sale of the Concentrate Interest to the Investor and have not entered into an agreement within 90 days of delivery of the ROFR Acceptance Notice, then the Corporation or such Affiliate shall be permitted to sell the Concentrate Interest to the applicable Third Party pursuant to terms and conditions contained in the ROFR Offer. Such sale must be completed within 60 days of the expiry of the 45-day period set forth in Section 6.3(a), failing which, the Corporation shall again be required to comply with the terms of this Section 6.3 before selling the Concentrate Interest to a Third Party.

(a)The Corporation covenants and agrees that it shall not undertake an Offering of Offered Securities prior to the six month anniversary of the Closing Date.

(b)During the six month period commencing on the six month anniversary of the Closing Date, the Corporation covenants and agrees that it shall not undertake any Offering of Offered Securities unless such Offering (a “Permitted Offering”) complies with the following requirements:

(c)Subject to Section 6.4(d), the Investor shall be entitled to exercise its Participation Right in connection with any Permitted Offering and covenants and agrees that, subject to the receipt of any required shareholder approvals, it will purchase any additional Common Shares offered in the Permitted Offering that are not sold to Third Parties at the Offer Price and otherwise on substantially the same terms and conditions as in the Permitted Offering (the “Standby Commitment”) (provided that, if the Investor is prohibited by Canadian Securities Laws or other

​

-22-

​

applicable law from participating on substantially the same terms and conditions of the Permitted Offering, the Corporation shall use commercially reasonable efforts to enable the Investor to participate on terms and conditions that are as substantially similar as circumstances permit).

(d)The Corporation shall deliver notice in writing to the Investor of any intention to utilize the Standby Commitment at least five Business Days but not more than ten Business Days prior to the closing of the Permitted Offering and in any event prior to the one year anniversary of the date of this Agreement; provided that the Corporation shall be entitled to complete the sale of any Common Shares to be sold in the Permitted Offering to Third Parties no more than ten days prior to completing the sale to the Investor pursuant to the Standby Commitment and the Participation Right.

ARTICLE 7

REGISTRATION RIGHTS

(a)At any time the Investor may, provided that the Investor continues to hold at least 10% of the issued and outstanding Common Shares, require the Corporation to file a Prospectus and take such other steps as may be necessary to facilitate a Distribution in Canada of all or any portion of the Registrable Securities held by the Investor (the “Demand Registration”). Any such request shall be made by a notice in writing (a “Request”) to the Corporation and shall specify the number and the class or classes of Registrable Securities to be sold (the “Designated Registrable Securities”) by the Investor, the intended method of disposition, whether such offer and sale shall be made by an underwritten public offering and the jurisdiction(s) in which the filing is to be effected. The Corporation shall, subject to applicable Canadian Securities Laws, use its commercially reasonable efforts to file one or more Prospectuses in compliance with applicable Canadian Securities Laws, in order to permit the Distribution in Canada of all of the Designated Registrable Securities of the Investor specified in a Request. The Parties shall cooperate in a timely manner in connection with such Distribution and the procedures in Schedule B shall apply.

(b)The Corporation shall not be obliged to effect:

​

-23-

​

(c)In the case of an underwritten public offering of Registrable Securities initiated pursuant to this Section 7.1, the Investor shall have the right to select the lead underwriter(s) or lead agent(s) and the counsel retained which will perform such offering, provided, however, that the Investor’s selection will be subject to the approval of the Corporation, acting reasonably, such approval not to be unreasonably withheld or delayed.

(d)If at any time the Investor requests a Demand Registration, the Corporation shall have the right, within ten days (except in the case of a “bought deal” in which case the Corporation shall have only 24 hours) of receipt of such request, to notify the Investor of its intention to Register for distribution to the public under such Prospectus (i) an offering of Common Shares from treasury or (ii) securities of the same class as the Designated Registrable Securities owned by Shareholders (the “Shareholder Securities”) with piggy back registration rights (the “Offering Shareholders”) (such as the right of Paulson pursuant to section 5.2 of the Paulson Investor Rights Agreement). The Investor shall use commercially reasonable efforts to include in the proposed distribution such number of Common Shares and Shareholder Securities as the Corporation shall request, upon the same terms (including the method of distribution) as such Demand Registration, subject to any Underwriter Cutback.

Each time the Corporation elects to proceed with the preparation and filing of a Prospectus under Canadian Securities Laws in connection with a proposed Distribution of any of its securities, whether by the Corporation or any Offering Shareholder, the Corporation shall give written notice thereof to the Investor as soon as practicable. In such event, the Investor shall be

​

-24-

​

entitled, by notice in writing given to the Corporation (a “Piggyback Registration Notice”) within ten days (except in the case of a “bought deal” in which case the Investor shall have only 24 hours) after the receipt of any such notice by the Investor, to require that the Corporation cause any or all of the Registrable Securities (the “Piggyback Registrable Securities”) held by the Investor to be included in such Prospectus (such qualification being hereinafter referred to as a “Piggyback Registration”), subject to any Underwriter Cutback. Any Distribution in respect of which there is a Piggyback Registration shall proceed in accordance with the procedures set forth in Schedule B. Notwithstanding the foregoing:

In connection with any exercise of the Demand Registration Right or Piggyback Registration Right, if the lead underwriter or lead agent for the offering determines in its good faith opinion that the inclusion of all of the Demand Registrable Securities, Piggyback Securities, Common Shares and/or Shareholder Securities proposed to be included in such offering may materially and adversely affect the price or success of the offering, then the amount of securities of the Corporation included in the offering will be prioritized in such offering, as follows (the “Underwriter Cutback”), but only to the extent necessary:

Subject to Section 7.2(a), all Registration Expenses incident to the performance of or compliance with this Article 7 by the Parties shall be borne by the Corporation, other than the following Registration Expenses, which shall be borne by the Investor:

​

-25-

​

After receipt by the Corporation of a Request, the Corporation shall not, without the prior written consent of the Investor, authorize, issue or sell any Common Shares or Equity Securities in any jurisdiction or agree to do so or publically announce any intention to do so (except for securities issued pursuant to any legal or contractual obligations in effect on the date of the Request or pursuant to any stock option plan or equity incentive plan) until the date which is 90 days after the later of (a) the date on which a Receipt is issued for the Prospectus filed in connection with such Demand Registration, and (b) the completion of the offering contemplated by the Demand Registration.

The Corporation shall not grant registration rights without the prior written consent of the Investor unless the granting of such registration rights does not limit, in any material respect, the registration rights granted to the Investor pursuant to this Agreement and such registration rights are not materially more favorable to the grantee than the registration rights granted to the Investor.

In connection with the preparation and filing of any Prospectus as herein contemplated, the Corporation shall give the Investor, its underwriters for an underwritten offering or agents for an agency offering, and their respective counsel, auditors and other representatives, the opportunity to participate in the preparation of such documents and each amendment thereof or supplement thereto, and shall insert therein such material furnished to the Corporation in writing, which in the reasonable judgment of the Investor and its counsel should be included. The Corporation shall give the Investor and the underwriters or agents such reasonable and customary access to the books and records of the Corporation and its subsidiaries and such reasonable and customary opportunities to discuss the business of the Corporation with its officers and auditors as shall be necessary in the reasonable opinion of the Investor, such underwriters or agents and their respective counsel. The Corporation shall cooperate with the Investor and its underwriters or agents in the conduct of all reasonable and customary due diligence which the Investor, such underwriters or agents and their respective counsel may reasonably require in order to conduct a reasonable investigation for purposes of establishing a due diligence defence as

​

-26-

​

contemplated by Canadian Securities Laws and in order to enable such underwriters or agents to execute the certificate required to be executed by them for inclusion in each such document.

(a)If requested by the underwriters for any underwritten offering or by the agents for any agency offering by the Investor pursuant to the exercise of a Demand Registration or Piggyback Registration, the Corporation will enter into an underwriting agreement with such underwriters or agency agreement with such agents for such offering, such agreement to be satisfactory in substance and form to each of the Investor and the Corporation and the underwriters or agents, each acting reasonably, and to contain such representations and warranties by the Corporation and such other terms as are generally prevailing in agreements of these types. The Investor shall be a party to such underwriting agreement or agency agreement and may, at its option, require that any or all of the representations and warranties by, and the other agreements on the part of, the Corporation to and for the benefit of such underwriters or agents shall also be made to and for the benefit of the Investor and that any or all of the conditions precedent to the obligations of such underwriters or agents under such underwriting agreement or agency agreement be conditions precedent to the obligations of the Investor. The Investor shall not be required to make any representations or warranties to or agreements with the Corporation or the underwriters’ or agents’ other than representations, warranties or agreements regarding the Investor and the Corporation’s intended method of distribution and any other representation required by law or as are generally prevailing in such underwriting or agency agreements for secondary offerings, as the case may be.

(b)The underwriting agreement or agency agreement, as applicable, referred to in Section 7.8(a) will contain customary terms, including an indemnity whereby in the event of the filing of a Prospectus, the Corporation will indemnify and hold harmless the Investor and each underwriter or agent involved in the distribution of Registerable Securities thereunder, and each of their affiliates, directors, officers, employees, agents, shareholders and limited partners against any losses, claims, expenses, damages or liabilities (including reasonable counsels’ fees and all amounts paid in settlement of any investigation, order, litigation, proceeding or claim) (“Losses”), joint or several, to which the Investor, or such underwriter or agent or any of their affiliates, directors, officers, employees, agents, shareholders or limited partners may become subject, insofar as such Losses (or actions in respect thereof), arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in any Prospectus, or any amendment or supplement thereof, including in the documents incorporated therein by reference, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading; provided, however, that the Corporation will not be liable in any such case if and to the extent that any such Losses arise out of or are based upon an untrue statement or alleged untrue statement or omission or alleged omission so made in conformity with information furnished by the Investor, such underwriter or agent.

(c)The Investor will indemnify and hold harmless the Corporation, its directors, officers, employees and agents to the same extent as the indemnity referred to in Section 7.8(b), but only with respect to information regarding the Investor furnished in writing by or on behalf of the Investor to the Corporation expressly for inclusion in any Prospectus. Notwithstanding anything to the contrary contained herein, the Investor’s obligations under the indemnity set out

​

-27-

​

in this Section 7.8(c) shall be limited to a maximum aggregate amount equal to the net proceeds of the offering received by the Investor pursuant to such offering.

(d)If reasonably requested by the underwriters or agents in connection with any underwritten offering or agency offering made pursuant to the exercise of a Demand Registration or Piggyback Registration, the Corporation shall cooperate with all reasonable requests made by the lead underwriter of such underwritten offering or lead agent of such agency offering respecting the attendance of the Corporation at road shows and participation of the Corporation in any efforts relating to the distribution and sale of the Designated Registrable Securities and Piggyback Registrable Securities, as the case may be.

ARTICLE 8

STANDSTILL AND VOTING

(a)Subject to the terms and conditions of this Section 8.1, for a period of three years following the date hereof, neither the Investor nor any of its Affiliates will, without the prior approval of the Corporation:

(b)The restrictions contained in Section 8.1(a) shall not apply to any acquisition by the Investor or its Affiliates of any voting securities of the Corporation and/or Convertible Securities beneficially owned by a Specified Securityholder or over which a Specified Securityholder exercises control or direction (a “Specified Securityholder Transaction”), or to any Share

​

-28-

​

Transaction completed pursuant to the Standby Commitment or otherwise in compliance with the terms of this Agreement.

(c)The restrictions contained in Section 8.1(a) shall terminate immediately upon the earlier of (each a “Spring Event”):

(iii)the date on which the Corporation or any of its Affiliates agrees to the sale of all or substantially all of the assets of the Corporation, on a consolidated basis, or announces an intention to do so; or

(iv)the date on which a Third Party enters into an agreement or makes a public announcement of a letter of intent with the Corporation to acquire, or acquires, (A) direct or indirect beneficial ownership of, (B) the right to exercise control or direction over, or (C) a combination of direct or indirect beneficial ownership of and the right to exercise control or direction over securities of the Corporation carrying more than 50% of the voting rights attached to the outstanding voting securities thereof.

Notwithstanding anything in this Agreement to the contrary, if a Spring Event occurs and the Investor or any of its Affiliates subsequently proceeds, in accordance with the terms of this Section 8.1(c), with any of the transactions or activities contemplated in Section 8.1(a) and in connection therewith is required by applicable laws or stock exchange rules to publicly disclose Confidential Information provided to the Investor by the Corporation, the Investor or such Affiliate may disclose that portion of such Confidential Information that it is legally required to disclose and shall provide the Corporation with a copy of any such public disclosure as soon as practicable thereafter.

(d)The restrictions in this Section 8.1 shall not prevent the Investor or any of its Affiliates from acquiring securities of the Corporation where such acquisition results from the Investor’s or any of its Affiliates’ acquisition of the securities of a Person or company which acquired the securities of the Corporation without the Investor’s solicitation or breach of this Agreement; provided that the purpose of such acquisition is not to circumvent the provisions of this Section 8.1.

(e)Notwithstanding anything in this Section 8.1, the Investor shall be permitted at any time to make a confidential proposal to the Board regarding any of the transactions or activities contemplated in Section 8.1(a), to enter into discussions or negotiations with the Board with respect

​

-29-

​

to the terms of any such transactions or activities and to enter into any agreement with the Corporation providing for or relating to the consummation of any such transactions or activities.

(f)If, as a result of a Specified Securityholder Transaction, the Investor (together with its Affiliates) has, directly or indirectly, beneficial ownership of, or control or direction over, more than 40% but less than 100% of the outstanding Common Shares of the Corporation (calculated in accordance with Section 1.8 of NI 62-104) (a “Triggering Ownership Percentage”), the Investor agrees that it will not undertake any further Share Transaction except: (i) with the prior approval of the Independent directors on the Board; (ii) by way of a bona fide take-over bid made by the Investor or one of its Affiliates to acquire all of the outstanding Common Shares of the Corporation, other than those Common Shares beneficially owned, or over which control or direction is exercised, by the Investor or any Person Acting Jointly or in Concert with the Investor; or (iii) by way of a negotiated transaction approved by the Independent directors on the Board, including a merger, amalgamation, arrangement or similar transaction, and, in each case, otherwise in compliance with the provisions of this Section 8.1.

(g)For greater certainty, the provisions of this Section 8.1 supersede the provisions contained in Section 8 of the Confidentiality Agreement.

At any meeting of Shareholders, the Investor may vote or abstain or withhold from voting its Treasury Shares in any manner it wishes. For a period of three years following the date hereof, the Investor agrees that, in respect of any voting securities of the Corporation that it owns or over which it exercises control or direction other than the Treasury Shares (the “Acquired Voting Securities”), it will not vote or cause to be voted such Acquired Voting Securities against any resolution that a majority of the Board has approved to be recommended to securityholders of the Corporation as set forth in the management information circular sent to securityholders of the Corporation in respect of such meeting and which resolution has been supported by more than 50% of the securityholders voting on such matter (excluding the Investor).

ARTICLE 9

MISCELLANEOUS

This Agreement shall terminate and all rights and obligations hereunder shall cease immediately at such time as the Investor ceases to hold at least 10% of the issued and outstanding Common Shares.

(a)This Agreement shall be governed by and construed under the laws of the Province of Ontario and the federal laws applicable therein.

(b)Each of the Parties irrevocably and unconditionally (i) submits to the non-exclusive jurisdiction of the courts of the Province of Ontario over any action or proceeding arising out of or relating to this Agreement, (ii) waives any objection that it might otherwise be entitled to assert to the jurisdiction

​

-30-

​

of such courts and (iii) agrees not to assert that such courts are not a convenient forum for the determination of any such action or proceeding.

(c)It is agreed and understood that monetary damages would not adequately compensate an injured Party for the breach of this Agreement by any Party, that this Agreement shall be specifically enforceable, and that any breach or threatened breach of this Agreement shall be the proper subject of a temporary or permanent injunction or restraining order, without bond. Further, each Party hereto waives any claim or defense that there is an adequate remedy at law for such breach or threatened breach.

All statements as to factual matters contained in the recitals, any certificate or other instrument delivered pursuant hereto in connection with the transactions contemplated hereby shall be deemed to be representations and warranties under this Agreement.

No amendment or waiver of any provision of this Agreement, nor any consent or approval to any departure therefrom, shall in any event be effective unless the same shall be in writing and executed by all Parties hereto.

The rights provided by this Agreement may only be assigned, in whole or in part, by the Investor to a Permitted Assign without the prior approval of the other Parties. Upon such assignment, the Permitted Assign shall be treated as the Investor for all purposes under this Agreement, except that any entitlements to notice and any entitlements to furnished documentation pursuant to this Agreement shall be satisfied by the Corporation through delivery to the transferring Investor on behalf of the Permitted Assign. Except as otherwise expressly provided, the provisions prescribed herein shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors, and administrators of the Parties and Permitted Assigns hereto.

This Agreement and the other agreements and documents delivered pursuant hereto and thereto constitute the full and entire understanding and agreement between the Parties with regard to the subject hereof and no Party shall be liable or bound to any other in any manner by any representations, warranties, covenants and agreements except as specifically set forth herein and therein.

If any provision of this Agreement is determined by a court of competent jurisdiction to be invalid, illegal or unenforceable in any respect, all other provisions of this Agreement shall nevertheless remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to either Party. Upon a determination that any term or other provision of this Agreement is invalid, illegal or incapable

​

-31-

​

of being enforced, the Parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the Parties as closely as possible.

It is agreed that no delay or omission to exercise any right, power, or remedy accruing to any holder, upon any breach, default or noncompliance of any Party under this Agreement shall impair any such right, power, or remedy, nor shall it be construed to be a waiver of any such breach, default or noncompliance, or any acquiescence therein, or of any similar breach, default or noncompliance thereafter occurring. It is further agreed that any waiver, permit, consent, or approval of any kind or character on any Party’s part of any breach, default or noncompliance under the Agreement or any waiver on such Party’s part of any provisions or conditions of this Agreement must be in writing and shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement, by law, or otherwise afforded to holders, shall be cumulative and not alternative.

The Corporation will provide the Investor with a reasonable opportunity to review and comment on each press release of the Corporation relating or referencing, in any way, this Agreement or the transactions contemplated herein, prior to the issuance thereof and incorporate any comments provided by the Investor, to the extent commercially reasonable.

Each of the Parties shall, from time to time hereafter and upon any reasonable request of the other, promptly do, execute, deliver or cause to be done, executed and delivered all further acts, documents and things as may be required or necessary for the purposes of giving effect to this Agreement.

The Parties hereby agree that if the Corporation determines that Canadian Securities Laws require it to file this Agreement (and any amendment hereto) on the Canadian Securities Administrators’ System for Electronic Document Analysis and Retrieval, www.SEDAR.com, the Investor shall be given prior notice of such filing and the opportunity to review and provide comments on the redactions to this Agreement (or of any amendment hereto) that should be made prior to such filing by the Corporation, and the Corporation shall file such redacted version only after incorporating any commercially reasonable comments of the Investor.

Any notice under this Agreement shall be given in writing and either delivered, sent by electronic means (including facsimile transmission or email) or mailed by prepaid registered post to the Party to receive such notice at the address, facsimile number or email address indicated below:

​

-32-

​

Midas Gold Corp.
890 – 999 West Hastings Street
Vancouver, British Columbia V6C 2W2

Attention:Chief Executive Officer
Facsimile ###-###-####
Email: ***@***

with a copy (which shall not constitute notice) to:

DuMoulin Black LLP

10^th Floor, 595 Howe Street

Vancouver, British Columbia V6C 2T5

​

Attention:Lucy Schilling
Facsimile ###-###-####
Email: ***@***

Barrick Gold Corporation

TD Canada Trust Tower

161 Bay Street, Suite 3700

Toronto, ON M5J 2S1
Canada

Attention:Kevin Thomson
Facsimile ###-###-####
Email ***@***

With a copy to:

Attention:General Counsel
Facsimile ###-###-####
Email ***@***

or such other address, facsimile number or email address as such Party may hereafter designate by notice in writing to the other Parties. If a notice is delivered, it shall be effective from the date of delivery; if such notice is sent by electronic means during normal business hours of the addressee, it shall be effective on the Business Day such notice is sent and, if not sent during normal business hours of the addressee, then on the Business Day following the date such notice is sent; and if such notice is sent by mail, it shall be effective seven Business Days following the date of mailing, excluding all days when normal mail service is interrupted.

This Agreement may be executed in any number of counterparts (whether by fax or other electronic means), each of which shall be deemed an original, but all of which together shall constitute one instrument.

​

-33-

​

IN WITNESS WHEREOF, the parties hereto have executed this Investor Rights Agreement as of the date set forth above.

​

​

​

​

​

SCHEDULE A

FORM OF INDEMNITY AGREEMENT

​

​

​

​

​

INDEMNITY AGREEMENT

THIS AGREEMENT is made as of ■, 2018,

B E T W E E N:

MIDAS GOLD CORP.,

a corporation governed by the laws of the Province of British Columbia,

(the “Corporation”),

- and -

■, an individual resident in ■,

(the “Indemnified Party”).

RECITALS:

NOW THEREFORE in consideration of the Indemnified Party acting or continuing to act as a director and/or officer of the Corporation or Other Entity, and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:

ARTICLE 1

DEFINITIONS AND PRINCIPLES OF INTERPRETATION

Whenever used in this Agreement, the following words and terms shall have the meanings set out below:

​

​

​

​

“Act” means the Business Corporations Act (British Columbia), as the same exists on the date of this Agreement or may hereafter be amended.

“Agreement” means this agreement, including all schedules, and all amendments or restatements as permitted, and references to “Article” or “Section” mean the specified Article or Section of this Agreement.

“Articles” means the articles of the Corporation, including any amendments or alterations thereto.

“Business Day” means any day, other than a Saturday or Sunday, on which commercial banks in Vancouver, British Columbia are open for commercial banking business during normal banking hours.

“Claim” includes any civil, criminal, administrative, investigative, demand, inquiry, hearing, discovery or other proceeding of any nature or kind (including arbitrations and mediations) in which the Indemnified Party is involved (excluding claims brought by the Indemnified Party) by reason of the Indemnified Party being or having been a director and/or officer of the Corporation or Other Entity whether threatened, anticipated, pending, commenced, continuing or completed, and any appeal thereof, as well as any other circumstances or situation in respect of which an Indemnified Party reasonably requires legal advice or representation concerning actual, possible or anticipated Losses by reason of the Indemnified Party being or having been a director and/or officer of the Corporation or Other Entity.

“Control Transaction” means any merger, amalgamation, take-over bid, arrangement, recapitalization, consolidation, liquidation, wind-up, dissolution, share exchange, material sale of assets or similar transaction in respect of the Corporation.

“Court” means a court of competent jurisdiction in British Columbia.

“Losses” includes all costs, disbursements, charges, awards, expenses, losses, damages (including punitive and exemplary), fees (including any legal, professional or advisory fees or disbursements), liabilities, amounts paid to settle or dispose of any Claim or satisfy any judgment, fines, penalties or liabilities, including as a result of a breach or alleged breach of any statutory or common law duty imposed on directors and/or officers, without limitation, and whether incurred alone or jointly with others, including any amounts which the Indemnified Party may reasonably suffer, sustain, incur or be required to pay in respect of the investigation, defence, settlement or appeal of or preparation for any Claim or with any action to establish a right to indemnification under this Agreement, and for greater certainty, includes all taxes (including income taxes), interest, penalties and related outlays of the Indemnified Party arising from any indemnification of the Indemnified Party by the Corporation pursuant to this Agreement.

“Notice of Articles” means the notice of articles of the Corporation, including any amendments or alterations thereto.

​

-2-

​

“Other Entity” means a Subsidiary and any other entity in respect of which the Indemnified Party was specifically requested by the Corporation to serve as a duly appointed director and/or officer or similar position(s) of such Other Entity.

“Parties” means the Corporation and the Indemnified Party collectively and “Party” means any one of them.

“Policy” means the directors’ and officers’ insurance policy listed on Schedule A, and any successor to such policy entered into by the Corporation (and any renewals or replacements thereof).

“Run-Off Coverage” has the meaning set out in Section 3.1(c).

“Subsidiary” has the meaning set out in the Act.

“Termination Date” has the meaning set out in Section 5.1(a).

In this Agreement:

​

-3-

​

jurisdiction or without affecting its application to other Parties or circumstances.

ARTICLE 2

OBLIGATIONS

​

-4-

​

and to indemnify and save harmless the Indemnified Party for such costs, charges and expenses of such action provided the Indemnified Party fulfils the conditions set out in Sections 2.1(a)(i) and 2.1(a)(ii) above and provided that such advance or indemnification is not prohibited under any applicable statute. The Indemnified Party hereby agrees to repay such funds advanced if the Indemnified Party ultimately does not fulfil the conditions set out in Sections 2.1(a)(i) and 2.1(a)(ii) above. In the event that the Indemnified Party is successful in its application, it shall be reimbursed by the Corporation for the expense incurred by the Indemnified Party in making the application.

The Indemnified Party shall give notice in writing to the Corporation as soon as practicable upon being served with any statement of claim, writ, notice of motion, indictment, subpoena, investigation order or other document commencing, threatening or continuing any Claim involving the Corporation or Other Entity or the Indemnified Party which may result in a claim for indemnification under this Agreement, and the Corporation agrees to give the Indemnified Party notice in writing as soon as practicable upon it or any Other Entity being served with any statement of claim, writ, notice of motion, indictment,

​

-5-

​

subpoena, investigation order or other document commencing or continuing any Claim involving the Indemnified Party. Such notice shall include a description of the Claim, a summary of the facts giving rise to the Claim and, if possible, an estimate of any potential liability arising under the Claim. Failure by the Indemnified Party to so notify the Corporation of any Claim shall not relieve the Corporation from liability under this Agreement except to the extent that the failure materially prejudices the Corporation.

Promptly after receiving written notice from the Indemnified Party of any Claim (other than a Claim by or on behalf of the Corporation or Other Entity to procure a judgment in its favour against the Indemnified Party), the Corporation may by notice in writing to the Indemnified Party, in a timely manner assume conduct of the defence thereof and retain counsel on behalf of the Indemnified Party who is reasonably satisfactory to the Indemnified Party, to represent the Indemnified Party in respect of the Claim. On delivery of such notice by the Corporation, the Corporation shall not be liable to the Indemnified Party under this Agreement for any fees and disbursements of counsel the Indemnified Party may subsequently incur with respect to the same matter. In the event the Corporation assumes conduct of the defence on behalf of the Indemnified Party, the Indemnified Party consents to the conduct thereof and of any action taken by the Corporation, in good faith, in connection therewith, and the Indemnified Party shall fully cooperate in such defence including, without limitation, the provision of documents, attending examinations for discovery, making affidavits, meeting with counsel, testifying and divulging to the Corporation all information reasonably required to defend or prosecute the Claim.

If the Indemnified Party is named as a party or a witness to any Claim, or the Indemnified Party is questioned or any of his or her actions, omission or activities are in any way investigated, reviewed, or examined in connection with or in anticipation of any actual or potential Claims, the Indemnified Party will be entitled to retain independent legal counsel at the Corporation’s expense (limited to reasonable attorney’s fees and expenses) to act on the Indemnified Party’s behalf to provide an initial assessment to the Indemnified Party of the appropriate course of action for the Indemnified Party. The Indemnified Party will be entitled to continued representation by independent counsel at the Corporation’s expense (limited to reasonable attorney’s fees and expenses) beyond the initial assessment if:

​

-6-

​

No admission of liability with respect to the Indemnified Party shall be made by the Corporation without the prior written consent of the Indemnified Party unless such settlement includes an unconditional general release of the Indemnified Party without any admission of negligence, misconduct, liability or responsibility by the Indemnified Party.

(a)For purposes of any determination hereunder, the Indemnified Party will be deemed, subject to compelling evidence to the contrary, to have acted in good faith and in the best interests of the Corporation (or any Other Entity). The Corporation will have the burden of establishing otherwise.

(b)Unless a Court otherwise has held or decided that the Indemnified Party is not entitled to be fully or partially indemnified under this Agreement, the determination of any Claim by judgment, order, settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not, of itself, create any presumption for the purposes of this Agreement that the Indemnified Party is not entitled to indemnity under this Agreement.

(c)The knowledge and/or actions, or failure to act, of any other director, officer, agent or employee of the Corporation or any Subsidiary or Other Entity will not be imputed to the Indemnified Party for purposes of determining the right to indemnification under this Agreement.

ARTICLE 3

INSURANCE

(a)The Policy - The Corporation will ensure that its liabilities under this Agreement, and the potential liabilities of the Indemnified Party that are subject to indemnification by the Corporation pursuant to this Agreement, are at all times supported by the Policy. The Corporation shall pay all premiums payable under the Policy and, provided that such insurance is, in the Corporation’s reasonable and good faith opinion, available on commercially reasonable terms, take all steps necessary to maintain the coverage provided under the Policy. As may be required by the Policy, the Corporation will immediately notify the Policy’s insurers of any occurrences or situations that could potentially trigger a claim under the Policy and will promptly advise the Indemnified Party that the insurers have been notified of the potential claim. If, for any reason whatsoever, any directors’, and officers’ liability insurer asserts that the Indemnified Party is subject to a deductible under any existing or future directors’ and officers’ liability insurance purchased and maintained by the Corporation for the benefit of the Indemnified Party and the Indemnified Party’s heirs and legal representatives, the Corporation shall pay the deductible for and on behalf of the Indemnified Party. If any payments made by an insurer under a Policy are deemed to constitute a taxable benefit or otherwise become subject to any tax payable by the Indemnified Party, the Corporation agrees to pay any amount as may be necessary to ensure that the amount received by or on behalf of the Indemnified Party after the payment of, or

​

-7-

​

withholding for, such tax, fully reimburses the Indemnified Party for the actual cost, expense or liability incurred by or on behalf of the Indemnified Party.

(b)Variation of Policies - So long as the Indemnified Party is a director, officer or holder of a similar office of the Corporation or an Other Entity and provided that such insurance is, in the Corporation’s reasonable and good faith opinion, available on commercially reasonable terms, the Corporation shall not seek to amend adversely or discontinue the Policy or allow the Policy to lapse (without entering into a renewal or replacement thereof on similar terms) without the Indemnified Party’s prior written consent, acting reasonably. Should the Indemnified Party cease to be a director and/or officer of the Corporation, for any reason whatsoever, the Corporation shall continue to purchase and maintain directors’ and officers’ liability insurance for the benefit of the Indemnified Party and the Indemnified Party’s heirs and legal representatives, such that the Indemnified Party’s insurance coverage is, at all times up to and including the Termination Date, the same as any insurance coverage the Corporation purchases and maintains for the benefit of its then current directors and/or officers from time to time.

(c)Run-Off Coverage - In the event the Policy is discontinued for any reason, or in the event of a consummation of a Control Transaction, the Corporation shall purchase, maintain and administer, or cause to be purchased, maintained and administered for a period of six years after such discontinuance or the effective time of the Control Transaction, insurance for the benefit of the Indemnified Party (the “Run-Off Coverage”), on similar terms to the extent permitted by law and provided such Run-Off Coverage is available on commercially acceptable terms and premiums (as determined by the board of directors in its reasonable and good faith opinion), provided that the premiums for the Run-Off Coverage will be deemed to be commercially acceptable if the total premiums for such Run-Off Coverage do not exceed 300% of annual premiums under the Policy at the time they are discontinued). The Run-Off Coverage shall provide coverage only in respect of events occurring prior to the discontinuance of the Policy or the effective time of the Control Transaction. The Corporation will provide to the Indemnified Party a copy of each policy of insurance providing the coverages contemplated by this subsection 3.1(c) promptly after coverage is obtained and evidence of each annual renewal thereof and will promptly notify the Indemnified Party if the insurer cancels, makes material changes to coverage, or refuses to renew coverage (or any part of the coverage).

(d)Exclusion of Indemnity - Notwithstanding any other provision in this Agreement, the Corporation shall not be obligated to indemnify the Indemnified Party for any Losses for which the Indemnified Party is entitled to indemnity to pursuant any valid and collectible policy of insurance obtained and maintained by the Corporation, to the extent of the amounts actually collected by the Indemnified Party under such insurance policy. Where partial indemnity is provided by such insurance policy, the obligation of the Corporation under Section 2.1 shall continue in effect but be limited to that portion of the Losses for which indemnity is not provided by such insurance policy.

​

-8-

​

ARTICLE 4

MISCELLANEOUS

The Corporation and the Indemnified Party shall, from time to time, provide such information and cooperate with the other, as the other may reasonably request, in respect of all matters under this Agreement.

This Agreement shall be deemed to have effect as and from the first date that the Indemnified Party became a director or officer, or held a position equivalent to that of a director or officer, of the Corporation or Other Entity and shall apply to all actions and proceedings, whether such action or proceeding is in respect of facts arising before or subsequent to the effective date of this Agreement.

The liability of the Corporation under this Agreement shall not be affected, discharged, impaired, mitigated or released by reason of the discharge or release of the Indemnified Party in any bankruptcy, insolvency, receivership or other similar proceeding of creditors to the extent permitted by applicable laws.

No action or proceeding brought or instituted under this Agreement and no recovery pursuant thereto shall be a bar or defence to any further action or proceeding which may be brought under this Agreement.

The Corporation shall provide the Indemnified Party with all of the indemnifications, protections and benefits it may provide pursuant to the Act. The indemnification provided by this Agreement shall not exclude any separate rights of indemnification to which the Indemnified Party may otherwise be entitled under the Articles of the Corporation, the Act, any valid and lawful agreement, vote of shareholders or disinterested directors or otherwise, both as to action in the Indemnified Party’s official capacity and as to action in another capacity while holding such office, and such separate rights of indemnification shall continue if the Indemnified Party has ceased to be a director or officer of the Corporation or Other Entity, as the case may be, and shall enure to the benefit of the heirs, executors and administrators of the Indemnified Party.

To the extent that the terms of this Agreement are contrary to the provisions of the Act, as amended from time to time, or other applicable laws, the terms of this Agreement shall be deemed to be amended to comply therewith (it being understood that nothing contained herein shall be considered to impose an obligation upon the Corporation

​

-9-

​

which it is prohibited from complying with by virtue of such legislation). To the extent that the terms of this Agreement are contrary to the provisions of the Act, as amended from time to time, or other applicable laws, the terms of this Agreement shall be deemed to be amended to comply therewith (it being understood that nothing contained herein shall be considered to impose an obligation upon the Corporation which it is prohibited from complying with by virtue of such legislation).

ARTICLE 5

GENERAL

(a)The obligations of the Corporation under this Agreement shall survive until the date (the “Termination Date”) that is six years after the Indemnified Party has ceased to be a director and/or officer of the Corporation or Other Entity, except with respect to Claims that have been commenced as of the Termination Date in respect of which the Indemnified Party is entitled to claim indemnification under this Agreement.

(b)The obligations of the Corporation under this Agreement with respect to Claims that have been commenced as of the Termination Date in respect of which the Indemnified Party is entitled to claim indemnification under this Agreement shall survive until the final termination or resolution of such Claims.

Neither Party may assign this Agreement or any rights or obligations under this Agreement without the prior written consent of the other Party.

This Agreement enures to the benefit of and is binding upon the Parties and the heirs, attorneys, guardians, estate trustees, executors, trustees, administrators and permitted assigns of the Indemnified Party and the successors (including any successor by reason of amalgamation) and permitted assigns of the Corporation.

No amendment, supplement, modification or waiver or termination of this Agreement and, unless otherwise specified, no consent or approval by any Party, is binding unless executed in writing by the Party to be so bound. For greater certainty, the rights of the Indemnified Party under this Agreement shall not be prejudiced or impaired by permitting or consenting to any assignment in bankruptcy, receivership, insolvency or any other creditor’s proceedings of or against the Corporation or by the winding-up or dissolution of the Corporation.

Any notice, consent or approval required or permitted to be given in connection with this Agreement (in this Section referred to as a “Notice”) shall be in writing

​

-10-

​

and shall be sufficiently given if delivered (whether in person, by courier service or other personal method of delivery), or if transmitted by e-mail:

■ [name]
■ [address]

E-mail: ■

Midas Gold Corp.

1250 – 999 West Hastings Street
Vancouver, BC V6C 2W2

Attention:Chief Executive Officer
Email ***@***

Any Notice delivered or transmitted to a Party as provided above shall be deemed to have been given and received on the day it is delivered or transmitted, provided that it is delivered or transmitted on a Business Day prior to 5 :00 p.m. local time in the place of delivery or receipt. If the Notice is delivered or transmitted after 5:00 p.m. local time or if such day is not a Business Day, then the Notice shall be deemed to have been given and received on the next Business Day.

Any Party may, from time to time, change its address by giving Notice to the other Party in accordance with the provisions of this Section.

The Corporation and the Indemnified Party shall, with reasonable diligence, do all things and execute and deliver all such further documents or instruments as may be necessary or desirable for the purpose of assuring and conferring on the Indemnified Party the rights created or intended by this Agreement and giving effect to and carrying out the intention or facilitating the performance of the terms of this Agreement, or evidencing any loan or advance made pursuant to Section 2.1(c) hereof. The Corporation further covenants and agrees that it will not take any action, including, without limitation, the enacting, amending, or repealing of any by-law, which would in any manner adversely affect or prevent the Corporation’s ability to perform its obligations under this Agreement.

The Indemnified Party acknowledges that the Indemnified Party has been advised to obtain independent legal advice with respect to entering into this Agreement, that the Indemnified Party has obtained such independent legal advice or has expressly determined not to seek such advice, and that the Indemnified Party is entering into this

​

-11-

​

Agreement with full knowledge of the contents hereof, of the Indemnified Party’s own free will and with full capacity and authority to do so.

This Agreement may be executed by the Parties in any number of counterparts, each of which is deemed to be an original, and such counterparts together shall constitute one and the same instrument. Transmission of an executed signature page by facsimile, email or other electronic means is as effective as a manually executed counterpart of this Agreement.

[Remainder of page left intentionally blank.]

​

​

-12-

​

IN WITNESS OF WHICH the Parties have duly executed this Agreement as of the date first written above.

​

​

​

​

​

​

SCHEDULE A

INSURANCE POLICY

​

​

​

​

​

​

SCHEDULE B

REGISTRATION PROCEDURES

1.1Registration Procedures

(a)Upon receipt of a Request or a Piggyback Registration Notice from the Investor pursuant to Article 7, the Corporation will use its commercially reasonable efforts to effect the qualification for the offer and sale or other disposition or Distribution of Registrable Securities or Piggyback Registrable Securities, as applicable, of the Investor, and pursuant thereto the Corporation will use its commercially reasonable efforts to as expeditiously as possible:

​

​

​

​

2

​

and their respective counsel in connection with the qualification of such Registrable Securities or Piggyback Registrable Securities, as applicable, for offer and sale in Canada in compliance with the applicable Canadian Securities Laws as any such Person, underwriter or agent reasonably requests in writing;

(xiii)provide a CUSIP number for all Registrable Securities not later than the closing date of the offering;

​

3

​

(b)In connection with each Demand Registration and Piggyback Registration in which the Investor sells Registrable Securities or Piggyback Registrable Securities, as

​

4

​

applicable, the Corporation may require the Investor to furnish to the Corporation such information regarding the Distribution and such other information relating to the Investor and its ownership of Registrable Securities or Piggyback Registrable Securities, as applicable, as the Corporation may from time to time reasonably request in writing. The Investor agrees to furnish such information to the Corporation and to cooperate with the Corporation as necessary to enable the Corporation to comply with the provisions of this Agreement. The Investor shall notify the Corporation immediately upon the occurrence of any event as a result of which any Prospectus or any amendment or supplement thereto includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances under which they are made.

1.2Investor’s Rights of Withdrawal

(a)The Investor shall have the right to withdraw its request for inclusion of its Registrable Securities or Piggyback Registrable Securities in any Prospectus pursuant to Section 7.1 or Section 7.2, as applicable, without incurring any liability to the Corporation or any other Person by giving written notice to the Corporation of its request to withdraw; provided, however, that:

(b)Provided that the Investor withdraws all of its Registrable Securities or Piggyback Registrable Securities, as applicable, from a Demand Registration or a Piggyback Registration in accordance with Section 1.2(a) of this Schedule B prior to the filing of a preliminary Prospectus, the Investor will be deemed to not have participated in or requested such Demand Registration or a Piggyback Registration, as applicable.

(c)Notwithstanding Section 1.2(a)(i) of this Schedule B, if the Investor withdraws its request for inclusion of its Registrable Securities or Piggyback Registrable Securities from a Demand Registration or Piggyback Registration, as applicable, at any time after having learned of a material adverse change in the condition, business or prospects of the Corporation, the Investor will not be deemed to have participated in or requested such Demand Registration or Piggyback Registration.

(d)Notwithstanding the foregoing, if the Corporation postpones the filing of a Prospectus pursuant to Section 7.1(b)(iii) of the Agreement and if the Investor, at any time prior to receiving written notice that the Valid Business Reason for such postponement no longer exists, advises the Corporation in writing that it has determined to withdraw its request for a Demand Registration, then such Demand Registration and the request therefor will be deemed to be withdrawn and such request will be deemed not to have been made for purposes of determining whether the Investor exercised its right to a Demand Registration.

​

5

​

SCHEDULE C

SELECTION OF INDEPENDENT EXPERT

If an Equivalency Determination Request is delivered by the Corporation pursuant to Section 6.3(c), the Parties shall work together to select a senior executive from an internationally recognized firm acting in the area of precious metal concentrate sales, trading and marketing that is carrying on business in Canada and/or the United States and that is independent of each of the Corporation and the Investor (an “Independent Expert”). For purposes of selecting an Independent Expert, the Parties have pre-approved Cliveden Trading AG and Bluequest Resources AG as acceptable firms from which a senior executive may be selected but, if such firms are not available or independent of each of the Corporation and the Investor, the Parties may select a senior executive from an internationally recognized firm, such as SNC-Lavalin Group Inc., Hatch Ltd., Fluor Corporation or AMEC Foster Wheeler plc, that is independent of each of the Corporation and the Investor. If the Parties do not agree to an Independent Expert within 10 days of the delivery by the Corporation of an Equivalency Determination Request, each Party shall nominate one Independent Expert within the following 10 days and both such Independent Experts acting together shall within a further 10 day period select a third Independent Expert to make such determination; provided that, if one of the Parties fails to appoint an Independent Expert pursuant to the foregoing, the Independent Expert appointed by the other Party shall be entitled to make the determination requested in the Equivalency Determination Request. In the event that the Independent Experts selected by the Parties fail to appoint an Independent Expert to make the Equivalency Determination within the prescribed time, the Chief Executive Officer of the Corporation and a senior executive of the Investor shall meet within 10 days (in person or by teleconference) to use good faith efforts to select an Independent Expert.

6